在驾驶和穿越道路时感知危险的能力的差异在中风后的患者和健康人口之间
Amit Timor1, Tova Rosenbloom2, Navah Z Ratzon3
1Occupational Therapy Department, School of Health Professions, Tel Aviv University, Tel Aviv, Israel.
Traffic injury prevention
|September 12, 2025
概括
与健康人相比,中风后患者在行人中表现出危险感知受损. 他们的驾驶和行人危险感知技能有很强的相关性,突出了全面评估的必要性.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 交通安全 交通安全
背景情况:
- 卒中幸存者面临的挑战影响日常活动,如驾驶和行人安全.
- 关于中风后个体的危险感知研究有限,特别是在驾驶和行人角色方面.
研究的目的:
- 为了比较中风后成年人和健康对照者在十字路口和驾驶场景中的危险感知.
- 确定中风后个体安全驾驶技能和安全交叉路口能力之间的相关性.
主要方法:
- 一项涉及30名中风后成年人和28名健康对照者的横截面研究.
- 计算机工具被用来评估驾驶和行人环境中的危险感知.
- 用问卷对驾驶员和行人行为进行分类.
主要成果:
- 与对照组相比,中风后的患者在行人中表现出明显较低的危险感知.
- 脑卒中后的患者报告说,驾驶员的错误和攻击性更少.
- 在驾驶和行人角色中的危险感知能力之间发现了强烈的显著相关性.
结论:
- 评估中风后个体的危险感知对于评估驾驶能力和行人安全至关重要.
- 驾驶和行人危险感知之间的相关性强调了综合临床评估的必要性.
- 临床医生在中风康复和计划中应考虑驾驶能力和行人安全.
相关概念视频
Factors Affecting Illness
5.4K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.4K
Factors Affecting the Risk of Infection
14.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Hazard Ratio
756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
756


